Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Source: Eur Respir J 2002; 20: 799-805 Year: 2002
Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009
Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs) Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
Translating research into practice: how are guidelines implemented? Source: Eur Respir J 2003; 21: 23S-29S Year: 2003
Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011
Prevalence of chronic obstructive pulmonary disease in Japan: results from the Nippon COPD epidemiology (NICE) study Source: Eur Respir J 2001; 18: Suppl. 33, 275s Year: 2001
Healthcare utilization and economic burden of patients with diagnosed chronic obstructive pulmonary disease in Korea Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
European COPD Audit: design, organisation of work and methodology Source: Eur Respir J 2013; 41: 270-276 Year: 2013
Diet and related lifestyle, lung function and chronic obstructive pulmonary disease in Middle Eastern and African countries: A systematic review Source: International Congress 2014 – Chronic and acute environmental exposure effect during childhood and in the elderly Year: 2014
Medical and demographic loss of population due to chronic obstructive pulmonary disease Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Current maintenance treatment of chronic obstructive pulmonary disease in China Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
Population surveillance in North West Adelaide: the impact of diagnosed and undiagnosed chronic obstructive pulmonary disease (COPD) on quality of life Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005
Estimates of chronic obstructive pulmonary disease in terms of prevalence, mortality and costs for England and Scotland for 2011 and 2030 Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
The burden of obstructive lung disease (BOLD) methodology overestimates the prevalence of COPD: A 5-year follow-up study Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
Clinical highlights from the 2011 ERS Congress in Amsterdam Source: Eur Respir J 2012; 39: 1501-1510 Year: 2012
Present and future costs of COPD in Iceland and Norway: results from the BOLD study Source: Eur Respir J 2009; 34: 850-857 Year: 2009
Epidemiology of COPD: social burden and trends for the future Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006
The burden of chronic obstructive pulmonary disease (COPD) in Taiwan Source: Annual Congress 2013 –Health economics of airway diseases Year: 2013
Population surveillance in North West Adelaide: physical activity associated with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 383s Year: 2005
Hidden realities of COPD among the very old Source: Eur Respir Mon; 2009: 43: 77–89 Year: 2009